flufenamic acid has been researched along with Bright Disease in 1 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasero, G | 1 |
| Corsini, G | 1 |
| Palia, R | 1 |
| Rindi, P | 1 |
1 other study available for flufenamic acid and Bright Disease
| Article | Year |
|---|---|
Proteinuria-lowering effect of anti-inflammatory drugs.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Child; Female; Flufe | 1974 |